Planet 13 Holdings (PLNH) Cash & Equivalents (2020 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Cash & Equivalents of $6.0 million for Q1 2026, down 61.39% year-over-year from $15.6 million in Q1 2025, and up 12.81% quarter-over-quarter from $5.3 million in Q4 2025.
Planet 13 Holdings (PLNH) Cash & Equivalents (2020 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Cash & Equivalents for 7 consecutive years, with $6.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Equivalents fell 61.39% year-over-year to $6.0 million; the TTM figure through Mar 2026 stood at $6.0 million (down 61.39% YoY), while the FY2025 annual figure was $5.3 million, down 77.23% from the prior year.
- Cash & Equivalents grew to $6.0 million in Q1 2026 per PLNH's latest filing, from $5.3 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $62.1 million in Q1 2022 and bottomed at $5.3 million in Q4 2025.
- Historically, Cash & Equivalents has averaged $25.9 million across 5 years, with a median of $23.4 million in 2024.
- Annual changes were most pronounced in 2022 — Cash & Equivalents surged 37349.39% — and 2025, when it slumped 77.23%.
- Planet 13 Holdings' Cash & Equivalents stood at $38.8 million in 2022, then plunged by 69.5% to $11.8 million in 2023, then soared by 97.65% to $23.4 million in 2024, then plunged by 77.23% to $5.3 million in 2025, then grew by 12.81% to $6.0 million in 2026.
- Business Quant data shows PLNH's Cash & Equivalents at $6.0 million in Q1 2026, $5.3 million in Q4 2025, and $17.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 164.00 Mn |
| 10 | Planet 13 Holdings | 52.64 Mn | 36.16 Mn | 12.32 Mn | 6.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.58 Mn |
| Mar 31, 2026 | 6.01 Mn |
| Dec 31, 2025 | 5.33 Mn |
| Sep 30, 2025 | 17.18 Mn |
| Jun 30, 2025 | 15.85 Mn |
| Mar 31, 2025 | 15.56 Mn |
| Dec 31, 2024 | 23.38 Mn |
| Sep 30, 2024 | 27.41 Mn |
| Jun 30, 2024 | 26.67 Mn |
| Mar 31, 2024 | 20.77 Mn |
| Dec 31, 2023 | 11.83 Mn |
| Sep 30, 2023 | 15.09 Mn |
| Jun 30, 2023 | 24.46 Mn |
| Mar 31, 2023 | 26.92 Mn |
| Dec 31, 2022 | 38.79 Mn |
| Sep 30, 2022 | 50.88 Mn |
| Jun 30, 2022 | 52.62 Mn |
| Mar 31, 2022 | 62.14 Mn |
| Dec 31, 2021 | 58.59 Mn |
| Sep 30, 2021 | 1.62 Mn |